Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126767231 | 12676723 | 1 | I | 20160809 | 20160823 | 20160823 | EXP | US-LUPIN PHARMACEUTICALS INC.-2016-03756 | LUPIN | SEARS S, GETZ T, AUSTIN C, PALMER W, BOYD E, STANCAMPIANO F. INCIDENCE OF SUSTAINED VENTRICULAR TACHYCARDIA IN PATIENTS WITH PROLONGED QTC AFTER THE ADMINISTRATION OF AZITHROMYCIN: A RETROSPECTIVE STUDY. DRUGS REAL WORLD OUTCOMES. 2016;3:99-105. | 91.00 | YR | M | Y | 0.00000 | 20160823 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126767231 | 12676723 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Intravenous (not otherwise specified) | 500 MG | UNKNOWN | 65398 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126767231 | 12676723 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126767231 | 12676723 | DE |
| 126767231 | 12676723 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126767231 | 12676723 | Arrhythmia | |
| 126767231 | 12676723 | Cardiac arrest |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |